An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.
作者:
主题词
消费品安全(Consumer Product Safety);药物处方(Drug Prescriptions);药品和麻醉品检定(Drug and Narcotic Control);人类(Humans);药用制剂(Pharmaceutical Preparations);产品监测, 售后(Product Surveillance, Postmarketing);美国(United States)
DOI
10.2165/00002018-200629020-00008
PMID
16454545
发布时间
2018-11-13
- 浏览32

Drug safety
175-81页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文